First Trust Nasdaq Pharmaceuticals ETF (FTXH) — ()
Key Metrics
News
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
Published: by:
Sentiment: Negative ()
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on …
Read More
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
Published: by:
Sentiment: Negative ()
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Read More
A Look at Pharma ETFs After Strong Q1 Earnings
Published: by:
Sentiment: Positive ()
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Read More
About First Trust Nasdaq Pharmaceuticals ETF FTXH
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.